Log in or Sign up for Free to view tailored content for your specialty!
Geriatric Oncology News
Older cancer survivors at higher risk for bone fracture
Older cancer survivors have an increased risk for pelvic and vertebral bone fracture compared with older adults without a history of cancer, research published in JAMA Oncology showed.
Most community-based oncologists don’t use, don’t see value in geriatric assessment
Cancer is a disease that disproportionately affects the elderly, and current guidelines recommend a comprehensive geriatric assessment for older patients with cancer.
Log in or Sign up for Free to view tailored content for your specialty!
Barriers to older-adult participation in cancer trials ‘likely exist above the patient’
Adults aged older than 70 years expressed the same level of interest in participating in cancer clinical trials as younger adults, according to study results in a research letter published in JAMA Network Open.
Older patients with advanced bladder cancer ‘want to be active participants in their care’
Bladder cancer disproportionately affects older individuals, with diagnosis occurring at a median age of 73 years.
Scale may help ‘quickly identify’ high-risk medications for older adults with blood cancer
Gerontology researchers and hematologic oncology investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute have devised a scale for assessing high-risk medications in older patients with blood cancers.
Nearly 75% of those who used medical aid in dying had cancer
Well-educated, white patients with cancer used medical aid in dying more than any other demographic, according to a study published in Journal of the American Geriatrics Society.
Age alone should not be barrier to hematopoietic stem cell transplantation consult
A patient aged 72 years with high-risk myelodysplastic syndrome presents at a community hematology/oncology clinic.
Geriatric assessment summary fosters patient-oncologist discussion of aging-related issues
Functional status is an important factor to consider when evaluating the overall health of older patients, especially those with cancer.
CAR-T demonstrates efficacy as second-line therapy for transplant-ineligible lymphoma
CHICAGO — Second-line therapy with lisocabtagene maraleucel induced initial complete remission among more than half of patients with relapsed or refractory transplant-ineligible large B-cell lymphoma, results from a phase 2 trial showed.
Healio’s Disruptive Innovators celebrate at ASCO 2022
CHICAGO – Healio gathered the best, brightest and boldest group of oncologists during the ASCO Annual Meeting in Chicago to celebrate our inaugural Healio Disruptive Innovators.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read